share_log

DR. ALESSIO FASANO APPOINTED AS CHIEF SCIENCE AND MEDICAL OFFICER

DR. ALESSIO FASANO APPOINTED AS CHIEF SCIENCE AND MEDICAL OFFICER

阿萊西奧·法薩諾博士被任命爲首席科學和醫療官
PR Newswire ·  2024/11/25 22:00

EVANSVILLE, Ind., Nov. 25, 2024 /PRNewswire/ -- Reckitt, a global leader in consumer health, hygiene and nutrition products, today announced the appointment of Dr. Alessio Fasano as the Chief Science and Medical Officer of the company's Mead Johnson Nutrition (MJN) business. A highly regarded scientific researcher and published author, Dr. Fasano will be responsible for creating and leading MJN's global science programs and further innovating the company's product portfolio which includes Enfamil and Nutramigen.

印第安納州埃文斯維爾,2024年11月25日 /美通社/--康培特(Reckitt),是全球領先的消費者健康、衛生和營養產品公司,今日宣佈任命亞歷西奧·法薩諾博士爲公司美讚美健營養(MJN)業務的首席科學和醫療官。作爲備受尊敬的科學研究員和發表作者,法薩諾博士將負責創建並領導MJN的全球科學項目,並進一步推動公司的產品組合創新,其中包括安滿美和營養美滋。

Dr. Alessio Fasano MD
亞歷西奧·法薩諾博士 MD

Dr. Fasano joins Reckitt/MJN from Mass General Brigham and will manage the science program for a $3.2B brand underpinned by robust clinical evidence that translates into innovative nutrition solutions for consumers. This newly created role will apply Dr. Fasano's talent and experience in medical science to help pioneer the next generation of nutrition products for people across multiple life stages, from infants to aging adults.

法薩諾博士從馬薩諸塞州總醫院布里格姆(Mass General Brigham)加入康培特/MJN,並將負責一家價值32億美元品牌的科學項目,該項目以強有力的臨床證據支撐,爲消費者提供創新的營養解決方案。這個新設立的職位將運用法薩諾博士在醫學科學方面的才華和經驗,幫助開創從嬰兒到老年人群的下一代營養產品。

"Mead Johnson was built on a foundation of science-based nutrition nearly 120 years ago, so we're honored to have a medical scientist of Alessio Fasano's caliber steering our scientific integrity and advancements," said Susan Sholtis, President of MJN. "Under Dr. Fasano's leadership, we will continue our journey of providing trusted nutrition products to families all over the world."

「美讚美健近120年前就是建立在基於科學的營養上,因此我們很榮幸能有亞歷西奧·法薩諾這樣一個醫學科學家來領導我們的科學誠信和進步,」MJN總裁蘇珊·肖爾蒂斯說。「在法薩諾博士的領導下,我們將繼續提供值得信賴的營養產品,造福世界各地的家庭。」

Dr. Fasano comes to MJN with a highly esteemed career, currently as the W. Allan Walker Chair of Pediatrics at Mass General Brigham, Professor of Pediatrics, and Professor of Nutrition. He is the Chief of the Division of Pediatric Gastroenterology and Nutrition, Vice Chair of Research and Director of the Mucosal Immunology and Biology Research Center at Mass General for Children. With more than 25 years of expertise in pediatric nutrition, Dr. Fasano is widely considered an expert in celiac disease, the gut microbiome, and autoimmune and inflammatory diseases. He has authored more than 450 peer-reviewed papers, filed more than 160 patent applications, and he has been cited over 69,000 times and since 2019 he has been among the Highly Cited Clarivate Researchers (top 1%) Worldwide.

法薩諾博士擁有備受推崇的職業生涯,目前擔任馬薩諸塞州總醫院布里格姆的W.艾倫·沃克兒科主席,兼任兒科教授和營養學教授。他是兒科胃腸病與營養學部主任、研究副主任和馬薩諸塞州兒童總醫院黏膜免疫學與生物學研究中心主任。法薩諾博士在兒科營養方面擁有逾25年的專業知識,被廣泛認爲是著名的乳糜瀉、腸道菌群以及自身免疫和炎症性疾病專家。他已發表了450多篇同行評議論文,提交了160多項專利申請,被引用超過69,000次,自2019年以來他一直是全球高被引研究員(佔全球前1%)之一。

"I am humbly honored and extremely excited to join Mead Johnson Nutrition to contribute to bringing the best nutritional science to clinical fruition for the most vulnerable populations, including infants, children and the elderly population," said Dr. Fasano, Chief Science and Medical Officer of MJN. "Our knowledge in this field has reached a level of maturity and can now be deployed in the care of a multitude of people who will benefit tremendously in reaching their goal of living healthier lives," he continued. "By continuing in my academic roles as Professor of Pediatrics and Professor of Nutrition, I will act as a bridge between academia and industry as we pursue crucial partnerships to bring superb science to medical fruition," concluded Dr. Fasano.

「我懷着謙卑的光榮感和極度興奮之情加入美贊臣營養,致力於將最佳營養科學運用到臨床實踐中,惠及包括嬰兒、兒童和老年人在內的最脆弱群體,」美贊臣的首席科學和醫學官法薩諾博士說道。「我們在這一領域的知識已經發展到一個成熟階段,現在可以在護理衆多人群中得到應用,這些人將極大受益,實現健康生活的目標,」他繼續說道。「作爲兒科教授和營養學教授,我將繼續擔任學術職務,作爲學術界和行業之間的橋樑,我們將追求關鍵合作伙伴關係,將出色的科學推向醫療實踐,」法薩諾博士總結道。

Dr. Fasano will be based out of MJN's headquarters in Evansville, Indiana, and will continue his activity as an ad hoc reviewer for the National Institutes of Health (NIH), serving as chair to many NIH study sections.

法薩諾博士將駐紮在位於印第安納州埃文斯維爾的美贊臣總部,並將繼續擔任美國國立衛生研究院(NIH)的臨時評審員,擔任許多NIH研究小組主席。

About Reckitt

關於Reckitt

Reckitt* exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

萊克存在的目的是在追求更清潔、更健康的世界中保護、治癒和培育。我們相信,獲得最高質量的衛生、健康和營養享受是一種權利,而不是一種特權。

Reckitt is the company behind some of the world's most recognizable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

Reckitt是一家全球最知名和信賴的消費品牌公司,涵蓋衛生、健康和營養領域,包括Air Wick、Calgon、Cillit Bang、Clearasil、Dettol、Durex、Enfamil、Finish、Gaviscon、Harpic、Lysol、Mortein、Mucinex、Nurofen、Nutramigen、Strepsils、Vanish、Veet、Woolite等等。

Every day, around 30 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

每天全球銷售約3000萬件Reckitt產品。我們始終將消費者和人放在首位,尋找新機遇,追求卓越,與所有合作伙伴共同取得成功。我們的宗旨是始終做正確的事。

We are a diverse global team of c. 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at .

我們是一個擁有約40000名同事的多元化全球團隊。我們發揮集體能量,實現品牌引領、更健康的地球和更公平的社會的雄心壯志。欲了解更多信息,請查詢,或與我們聯繫。

* Reckitt is the trading name of the Reckitt Benckiser group of companies

* Reckitt是瑞士百利集團的交易名稱

SOURCE Reckitt

資訊來源:Reckitt

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎?

440k+
440k+

Newsrooms &
新聞發佈室&

Influencers
影響力人士
9k+
9k+

Digital Media
數字媒體

Outlets
Outlets
270k+
270k+

Journalists
記者

Opted In
Opted In
GET STARTED
開始使用

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論